Idosi enye yesitofu sokugonya inokunyuka lokugonya ukhuselo ngokukhawuleza into efunekayo kumazwe amaninzi apho inqanaba lokugonya ukufunxa akulunganga.
WHO ihlaziye izindululo zayo zethutyana1 kusetyenziso lwe-Janssen Ad26.COV2.S (Covid-19).
Ishedyuli yedosi enye yeJanssen lokugonya:
Ukusetyenziswa kwekhosi enye okanye ezimbini yesitofu sokugonya i-Janssen ngoku kunokuqwalaselwa.
Ishedyuli yedosi enye yi-EUL (uLuhlu lokuSebenzisa oluNgxamisekileyo) olugunyazisiweyo lwerejimeni.
Kwezinye iimeko, ukusebenzisa idosi enye kunokuba neenzuzo. Amazwe amaninzi ajongene nemiqobo enzima yokubonelela ngesitofu sokugonya, kudityaniswa nomthwalo omkhulu wezifo. Idosi enye yesitofu sokugonya iyasebenza kwaye yenza kube lula ukunyusa ukhuseleko lwesitofu ngokukhawuleza, nto leyo eya kuthi inciphise umthwalo kwiinkqubo zokhathalelo lwempilo ngokuthintela iziphumo zezifo ezinzima. Idosi enye inokuba yinto ekhethwayo yokugonya abantu ekunzima ukufikelela kubo okanye abantu abahlala kwiingxabano okanye kwiindawo ezingakhuselekanga.
Idosi yesibini yesitofu sokugonya:
Idosi yesibini inokufaneleka njengoko isitofu sokugonya kunye/okanye ukufikeleleka kunyuka. Amazwe kufuneka acinge ngokunikezela ngedosi yesibini, eqala ngezona ndawo ziphambili ngokubaluleka (umzekelo, abasebenzi bezempilo, abantu abadala, abantu abanezigulo) njengoko kubonisiwe kwi-WHO Prioritization Roadmap. Ukulawulwa kwedosi yesibini kuya kubangela ukukhuselwa okwandisiweyo ngokuchasene nosulelo lweempawu, kunye nesifo esibi.
Isitofu sokugonya esine-heterologous (umzekelo, isitofu sokugonya se-COVID-19 esivela kwelinye iqonga lesitofu sokugonya esifumene i-EUL) sinokuthathelwa ingqalelo kwidosi yesibini.
Isithuba phakathi kweedosi:
Amazwe anokuthathela ingqalelo ixesha elide phakathi kweedosi. Idosi yesibini kwiinyanga ezi-2 emva kwedosi yokuqala yonyusa kakhulu ukusebenza, ngakumbi ngokuchasene nosulelo oluneempawu, kubandakanywa xa kubangelwa kukwahluka kwe-SARS-CoV-2 yenkxalabo. Ithuba elide nangakumbi phakathi kweedosi ezimbini kunye ne-Ad26.COV2.S (iinyanga ezi-6 kuneenyanga ezi-2) libonakaliswe njengesiphumo sokunyuka okukhulu kwiimpendulo zamajoni omzimba kubantu abadala. Amazwe ke ngoko anokuthathela ingqalelo ikhefu lokuya kutsho kwiinyanga ezi-6 ngokusekwe kwimeko yawo ye-epidemiological, kunye neemfuno zabemi abancinci.
I ngxelo:
Njenge-Oxford/AstraZeneca's ChAdOx1, isitofu sokugonya se-Janssen Ad26.COV2.S (COVID-19) ikwasebenzisa ii-adenoviruses njengeevektha. Kukho ubungqina bokubadibanisa neziphumo ebezingalindelekanga ezinqabileyo zehlwili legazi njengoko zibophelela kwiplatelet factor 4 (PF4), iprotein ebandakanyeka kwi-pathogenesis ye-clotting disorders.2.
***
Imithombo:
- WHO 2021. Izindululo zethutyana zokusetyenziswa kwesitofu sokugonya i-Janssen Ad26.COV2.S (COVID-19). Isikhokelo sethutyana sihlaziywe nge-9 kaDisemba 2021. Iyafumaneka kwi-intanethi apha https://apps.who.int/iris/rest/bitstreams/1398839/retrieve
- Soni R., 2021.Ikamva le-Adenovirus esekwe kwi-COVID-19 Izitofu (ezifana ne-Oxford AstraZeneca) ekukhanyeni okufunyaniswe mva nje malunga nonobangela weziphumo ebezingalindelekanga ezinqabileyo zehlwili legazi. Inzululwazi yaseYurophu. Ithunyelwe nge-03 kuDisemba 2021. Iyafumaneka kwi-intanethi Apha
***
